Position in QURE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,452,500
+$2,452,500 QoQ
Shares Held
150,000
Ownership
0.238%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in QURE
reported options exposure · as of Mar 31, 2026CallValue
$817,500
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Creek Drive Management Group LLC holds $33,530,780 across 8 Biotechnology names. QURE ranks #3 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
155,000 | $17,259,250 | |
| 2 | NKTR |
Nektar Therapeutics
|
126,400 | $9,094,480 | |
| 3 | QURE |
uniQure N.V.
This page
|
150,000 | $2,452,500 | |
| 4 | RNA |
Atrium Therapeutics, Inc.
|
120,000 | $1,604,400 | |
| 5 | PALI |
Palisade Bio, Inc.
|
540,000 | $945,000 | |
| 6 | PEPG |
PepGen Inc.
|
450,000 | $796,500 | |
| 7 | TENX |
Tenax Therapeutics, Inc.
|
45,000 | $719,550 | |
| 8 | CYTK |
Cytokinetics Inc
|
10,000 | $659,100 |
All Filings in QURE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,452,500 | 150,000 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $817,500 | 50,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $7,179,000 | 300,000 | Call | Sole | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||